Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 75,000 | 8,000 | 5,000 | 10,000 | 16,684 |
| Gross Profit | 75,000 | 8,000 | 5,000 | 10,000 | 16,684 |
| Operating Expenses | 98,879 | 115,432 | 71,722 | 38,781 | 19,709 |
| Operating Income | -23,879 | -107,432 | -66,722 | -28,781 | -3,025 |
| Interest Expense | 0 | 1,041 | 1,652 | 1,775 | 458 |
| Other Income | 3,948 | 10,985 | 6,526 | 486 | -776 |
| Pre-tax Income | -19,931 | -97,488 | -61,848 | -30,070 | -4,259 |
| Income Tax | N/A | -152 | -192 | N/A | N/A |
| Net Income Continuous | -19,931 | -97,336 | -61,656 | -30,070 | -4,259 |
| Net Income | $-19,931 | $-97,336 | $-61,656 | $-30,070 | $-4,259 |
| EPS Basic Total Ops | -0.73 | -3.60 | -2.50 | -1.52 | -1.62 |
| EPS Basic Continuous Ops | -0.73 | -3.60 | -2.50 | -1.52 | -1.62 |
| EPS Diluted Total Ops | -0.73 | -3.60 | -2.50 | -1.52 | -1.62 |
| EPS Diluted Continuous Ops | -0.73 | -3.60 | -2.50 | -1.52 | -1.62 |
| EPS Diluted Before Non-Recurring Items | -0.73 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-21,801 | $-108,658 | $-67,640 | $-28,598 | $-2,792 |